Literature DB >> 21540489

Modelling of the oxygen enhancement ratio for ion beam radiation therapy.

Tatiana Wenzl1, Jan J Wilkens.   

Abstract

The poor treatment prognosis for tumours with oxygen-deficient areas is usually attributed to the increased radioresistance of hypoxic cells. It can be expressed by the oxygen enhancement ratio (OER), which decreases with increasing linear energy transfer (LET) suggesting a potential clinical advantage of high-LET radiotherapy with heavy ion beams compared to low-LET photon or proton irradiation. The aim of this work is to review the experimental cell survival data from the literature and, based on them, to develop a simple OER model to estimate the clinical impact of OER variations. For this purpose, the standard linear-quadratic model and the Alper-Howard-Flanders model are used. According to our calculations for a carbon ion spread-out Bragg peak at clinically relevant intermediate oxygen levels (0.5-20 mmHg), the advantage of carbon ions might be relatively moderate, with OER values about 1%-15% smaller than for protons. Furthermore, the variations of OER with LET are much smaller in vivo than in vitro due to different oxygen partial pressures used in cell experiments or measured inside tumours. The proposed OER model is a simple tool to quantify the oxygen effect in a practical way and provides the possibility to do hypoxia-based biological optimization in treatment planning.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21540489     DOI: 10.1088/0031-9155/56/11/006

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  33 in total

Review 1.  The evolution of practical radiobiological modelling.

Authors:  B Jones; R G Dale
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

2.  Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications.

Authors:  Tatiana Wenzl; Jan J Wilkens
Journal:  Radiat Oncol       Date:  2011-12-15       Impact factor: 3.481

3.  Spatio-Temporal Dynamics of Hypoxia during Radiotherapy.

Authors:  Harald Kempf; Marcus Bleicher; Michael Meyer-Hermann
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

4.  Influence of acute hypoxia and radiation quality on cell survival.

Authors:  Walter Tinganelli; Ning-Yi Ma; Cläre Von Neubeck; Andreas Maier; Corinna Schicker; Wilma Kraft-Weyrather; Marco Durante
Journal:  J Radiat Res       Date:  2013-07       Impact factor: 2.724

5.  Optimization of treatment planning for hypoxic tumours and re-modulation of radiation intensity in heavy-ion radiotherapy.

Authors:  Ladan Rezaee
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-17

Review 6.  MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy.

Authors:  Xanthene Miles; Charlot Vandevoorde; Alistair Hunter; Julie Bolcaen
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

7.  Differences in Phosphorylated Histone H2AX Foci Formation and Removal of Cells Exposed to Low and High Linear Energy Transfer Radiation.

Authors:  Thomas Ernst Schmid; Olga Zlobinskaya; Gabriele Multhoff
Journal:  Curr Genomics       Date:  2012-09       Impact factor: 2.236

8.  Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenation.

Authors:  Christian Wulbrand; Christof Seidl; Florian C Gaertner; Frank Bruchertseifer; Alfred Morgenstern; Markus Essler; Reingard Senekowitsch-Schmidtke
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

9.  Antiproton induced DNA damage: proton like in flight, carbon-ion like near rest.

Authors:  J N Kavanagh; F J Currell; D J Timson; K I Savage; D J Richard; S J McMahon; O Hartley; G A P Cirrone; F Romano; K M Prise; N Bassler; M H Holzscheiter; G Schettino
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  Kill-painting of hypoxic tumours in charged particle therapy.

Authors:  Walter Tinganelli; Marco Durante; Ryoichi Hirayama; Michael Krämer; Andreas Maier; Wilma Kraft-Weyrather; Yoshiya Furusawa; Thomas Friedrich; Emanuele Scifoni
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.